Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 1252 to 1301 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
METHYLENETETRAHYDROFOLATE REDUCTASE (EC 1.5.1.20). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.121247\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.490121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247381769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MTHFR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPORTIN 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.572386\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.31408\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247349271\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE PROTEIN KINASE 13 (EC 2.7.1.37) (AURORA/IPL1/EG2 PROTEIN 2) (AURORA/IPL1-RELATED KINASE 3) (AURORA-C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0283804\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.114745\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247334524\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AURKC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE KINASE 6 (EC 2.7.1.37) (SERINE/THREONINE KINASE 15) (AURORA/IPL1-RELATED KINASE 1) (AURORA-RELATED KINASE 1) (HARK1) (AURORA-A) (BREAST-TUMOR-AMPLIFIED KINASE). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0366317\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.148106\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.247334342\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
AURKA\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CYLINDROMATOSIS (TURBAN TUMOR SYNDROME); CYLINDROMATOSIS 1, TURBAN TUMOR SYNDROME. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
CYLD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE PROTEIN KINASE 12 (EC 2.7.1.37) (AURORA- AND IPL1- LIKE MIDBODY-ASSOCIATED PROTEIN 1) (AIM-1) (AURORA/IPL1-RELATED KINASE 2) (AURORA-RELATED KINASE 2) (STK-1) (AURORA-B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0285544\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.115449\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247333455\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AURKB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KINESIN-LIKE PROTEIN KIF23 (MITOTIC KINESIN-LIKE PROTEIN-1) (KINESIN- LIKE PROTEIN 5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.310673\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.25609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247333392\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIF23\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0339667\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.137332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247332741\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AQR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1260\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ISCHEMIA/REPERFUSION INDUCIBLE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0999509\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.404396\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247160951\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1261\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.12467\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.504447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24714192\vspace{3pt}}&\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1262\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0311675\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.126112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24714143\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SHQ1\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1263\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.110103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.445662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247054943\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C9orf7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAMIN B2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.481793\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.95026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.247040395\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BLOCK OF PROLIFERATION 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.872123\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.53236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246895277\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BOP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U6 SNRNA-ASSOCIATED SM-LIKE PROTEIN LSM8. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.115741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.46893\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246819355\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LSM8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOLAR RNA-ASSOCIATED PROTEIN ALPHA ISOFORM. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.966893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.91912\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246711762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NOL6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SINGLE-MINDED HOMOLOG 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0318532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.12912\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246694548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SIM1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PERIPHERAL PLASMA MEMBRANE PROTEIN CASK (EC 2.7.1.-) (HCASK) (CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE) (LIN-2 HOMOLOG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.685788\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.77992\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24669343\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CASK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HYPOXIA-INDUCIBLE FACTOR-3 ALPHA ISOFORM A; INHIBITORY PAS DOMAIN PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0415296\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.168345\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246693397\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HIF3A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.264834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.07406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246572817\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
I-KAPPA-B-INTERACTING RAS-LIKE PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0342893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.139064\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246572082\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NKIRAS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KAPPA B-RAS 1. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0384625\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.155989\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.246571874\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNARE ASSOCIATED PROTEIN SNAPIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SNAPAP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEASOME SUBUNIT BETA TYPE 9 PRECURSOR (EC 3.4.25.1) (PROTEASOME CHAIN 7) (MACROPAIN CHAIN 7) (MULTICATALYTIC ENDOPEPTIDASE COMPLEX CHAIN 7) (RING12 PROTEIN) (LOW MOLECULAR MASS PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.122196\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.495798\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246463277\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MAGUK P55 SUBFAMILY MEMBER 2 (MPP2 PROTEIN) (DISCS, LARGE HOMOLOG 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.123807\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.50235\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246455658\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGUK P55 SUBFAMILY MEMBER 6 (VELI-ASSOCIATED MAGUK 1) (VAM-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.143838\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.583751\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246403004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPP6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYB PROTO-ONCOGENE PROTEIN (C-MYB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.139096\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.564523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24639563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MYB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPSIN 1; EH DOMAIN-BINDING MITOTIC PHOSPHOPROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0423484\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.171872\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246394992\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EPN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CALRETICULIN PRECURSOR (CRP55) (CALREGULIN) (HACBP) (ERP60). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.205692\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.834998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246338315\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CALR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CATHEPSIN B PRECURSOR (EC 3.4.22.1) (CATHEPSIN B1) (APP SECRETASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.264212\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.07259\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246330844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CTSB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYSTEINE-RICH MOTOR NEURON 1; CYSTEINE-RICH REPEAT-CONTAINING PROTEIN S52 PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.516861\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.10021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246099676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CRIM1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1283\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NUCLEOSTEMIN; PUTATIVE NUCLEOTIDE BINDING PROTEIN, ESTRADIOL-INDUCED. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.856366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.47989\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246089963\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GNL3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1284\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.661293\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.68731\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246079909\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GNL3L\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1285\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0982055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.399189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24601254\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GPR158\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1286\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0245797\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0999171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246000935\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ISCA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1 (GTP-BINDING PROTEIN HSR1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.129655\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.527051\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246000861\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1288\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER-LIKE PROTEIN 9. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0473076\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.192307\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.246000406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZNF622\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1289\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN (AIM-1 PROTEIN) (MELANOMA ANTIGEN AIM1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0493513\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.200615\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24600005\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC45A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L19. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.864722\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.51639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245911858\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPL19\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1291\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
N-TERMINAL ACETYLTRANSFERASE COMPLEX ARD1 SUBUNIT HOMOLOG (EC 2.3.1.-). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.304267\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.23733\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245906104\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARD1A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1292\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ECOTROPIC VIRAL INTEGRATION SITE 5; NEUROBLASTOMA STAGE 4S GENE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0317084\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.128948\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245900673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EVI5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1293\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.111932\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.455193\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245900091\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C22orf23\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1294\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.160447\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.65249\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245899554\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RBMX2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1295\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0401118\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.163123\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.245899107\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
BUD13\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1296\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO ECOTROPIC VIRAL INTEGRATION SITE 5; NEUROBLASTOMA STAGE 4S GENE. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
EVI5L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1297\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.108852\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.442722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245869869\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UPRT\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1298\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0760628\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.309407\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245834128\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1299\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DELTA-AMINOLEVULINIC ACID DEHYDRATASE (EC 4.2.1.24) (PORPHOBILINOGEN SYNTHASE) (ALADH). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.154288\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.627636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245824013\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ALAD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1300\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BAG-FAMILY MOLECULAR CHAPERONE REGULATOR-3 (BCL-2 BINDING ATHANOGENE- 3) (BAG-3) (BCL-2-BINDING PROTEIN BIS) (DOCKING PROTEIN CAIR-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0975531\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.396904\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245785127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BAG3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAC GTPASE ACTIVATING PROTEIN 1; GTPASE ACTIVATING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.268542\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.09266\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.245769041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RACGAP1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/